Only three weeks ago we noted that the exoskeleton industry had made a number of significant advancements recently (“A Step in the Right Direction“). Since then one of our three exoskeleton stocks, Ekso Bionics (EKSO), got another big boost when it announced earlier this week that it received FDA… Read More

Only three weeks ago we noted that the exoskeleton industry had made a number of significant advancements recently (“A Step in the Right Direction“). Since then one of our three exoskeleton stocks, Ekso Bionics (EKSO), got another big boost when it announced earlier this week that it received FDA… Read More

As described in today’s edition of Smart Tech Investor, we are adding three smart car tech companies to the STI Special Situations Portfolio:NXP Semiconductors (NXPI) – buy limit $90Mobileye (MBLY) – buy limit $39Covisint Corp (COVS) – buy limit $2.35We recommend buying them all as a group to increase the probability of participating… Read More

As described in today’s edition of Smart Tech Investor, we are adding three smart car tech companies to the STI Special Situations Portfolio:NXP Semiconductors (NXPI) – buy limit $90Mobileye (MBLY) – buy limit $39Covisint Corp (COVS) – buy limit $2.35We recommend buying them all as a group to increase the probability of participating… Read More

This morning shares of Opko Health (OPK) fell hard in pre-market trading. The company received an FDA notice that it will not receive approval for its drug, Rayaldee.  What’s important here is that the denial was not directly related to Opko, but to the company that will manufacture the drug. … Read More

This morning shares of Opko Health (OPK) fell hard in pre-market trading. The company received an FDA notice that it will not receive approval for its drug, Rayaldee.  What’s important here is that the denial was not directly related to Opko, but to the company that will manufacture the drug. … Read More

We think the market is wrong about Opko Health (OPK). It’s acquisitions have already delivered profits and operating capital, buying it now could be an excellent long-term play. We are also looking to add this company to our EBIS list in the not too distant future.Opko’s strategy of consolidating its recent acquisitions resulted… Read More

We think the market is wrong about Opko Health (OPK). It’s acquisitions have already delivered profits and operating capital, buying it now could be an excellent long-term play. We are also looking to add this company to our EBIS list in the not too distant future.Opko’s strategy of consolidating its recent acquisitions resulted… Read More

Food. Science. Momentum.In the emerging world of applied science, Whitewave Food (NYSE: WWAV), a spinoff from Dean Foods is prototypical of an emerging sector, that of applied science without the emphasis on electronic products such as phones and PCs.  The company harnesses the power of nature with its focus on… Read More

Food. Science. Momentum.In the emerging world of applied science, Whitewave Food (NYSE: WWAV), a spinoff from Dean Foods is prototypical of an emerging sector, that of applied science without the emphasis on electronic products such as phones and PCs.  The company harnesses the power of nature with its focus on… Read More